Holen Sie sich die Stockscreener-App
43.84
2.01%
-0.90
Handel nachbörslich:
43.84
Schlusskurs vom Vortag:
$44.74
Offen:
$42.89
24-Stunden-Volumen:
1.38M
Relative Volume:
1.19
Marktkapitalisierung:
$1.26B
Einnahmen:
$915.25M
Nettoeinkommen (Verlust:
$131.14M
KGV:
9.8032
EPS:
4.472
Netto-Cashflow:
$96.71M
1W Leistung:
+9.46%
1M Leistung:
-19.11%
6M Leistung:
-51.22%
1J Leistung:
-69.96%
1-Tages-Spanne:
$42.60
$44.26
1-Wochen-Bereich:
$40.37
$44.98
52-Wochen-Spanne:
$39.61
$147.66
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
43.84 | 1.29B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Herabstufung | Truist | Buy → Hold |
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Inspire Medical Systems (INSP) Cuts 2026 Outlook Amid Medicare Uncertainty and Insider Sale – What’s Changed? - Sahm
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unveiling a Potential 18.99% Upside in the Healthcare Sector - DirectorsTalk Interviews
(INSP) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Inspire Medical drops as BofA cuts to underperform on lack of coding clarity - MSN
BofA Securities Downgrades Inspire Medical Systems(INSP.US) to Sell Rating, Cuts Target Price to $39 - Moomoo
Inspire Medical Systems (INSP) price target decreased by 17.14% to 72.73 - MSN
Inspire Medical Systems, Inc. Common Stock (NY: INSP - The Chronicle-Journal
BofA analysts downgrade Inspire Medical on reimbursement coding concerns - MassDevice
Inspire Medical Systems, Inc. Stock 12‑Month Price Target Cut to $52, Implies 16% Upside - TradingView
Inspire Medical Systems Faces Coding Overhang, Estimate Risks, BofA Says - Moomoo
Why is Inspire Medical stock sliding today? By Investing.com - Investing.com Canada
Inspire Medical stock cut to Underperform at BofA (INSP:NYSE) - Seeking Alpha
BofA downgrades Inspire Medical stock rating on coding concerns - Investing.com
BofA downgrades Inspire Medical stock rating on coding concerns By Investing.com - Investing.com Canada
BofA Securities Downgrades Inspire Medical Systems to Underperform From Neutral, Price Target is $39 - marketscreener.com
Inspire Medical Systems (INSP) Earnings Date and Reports 2026 $INSP - MarketBeat
Device to Prevent Airway Collapse During Sleep is Released in the U.K. - Medical Product Outsourcing
Insider Sell Alert: John Rondoni Sells Shares of Inspire Medical Systems Inc (INSP) - GuruFocus
Officer at Inspire Medical (NYSE: INSP) sells 2,641 shares - Stock Titan
Inspire Medical Systems, Inc. (INSP): Investor Outlook Highlights 33% Potential Upside - DirectorsTalk Interviews
INSP Technical Analysis | Trend, Signals & Chart Patterns | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
Inspire Medical Systems (INSP) Is Down 9.5% After Cutting 2026 Outlook And Filing ESOP Shelf RegistrationWhat's Changed - Sahm
Insider Sell Alert: John Rondoni Sells 700 Shares of Inspire Med - GuruFocus
[144] Inspire Medical Systems, Inc. SEC Filing - Stock Titan
Inspire Medical (INSP) officer sells 700 shares at about $43 - Stock Titan
Wellington Group reports 2.54M Inspire shares (INSP) representing 8.81% stake - Stock Titan
[SCHEDULE 13G/A] Inspire Medical Systems, Inc. Amended Passive Investment Disclosure - Stock Titan
INSP (NYSE) Form 144: Director/Holder Notices Sale of 700 Shares via Morgan Stanley - Stock Titan
How (INSP) Movements Inform Risk Allocation Models - Stock Traders Daily
Transcript : Inspire Medical Systems, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08 - marketscreener.com
5 Insightful Analyst Questions From Inspire Medical Systems’s Q1 Earnings Call - Yahoo Finance
What Does The Future Hold For Inspire Medical Systems, Inc. (NYSE:INSP)? These Analysts Have Been Cutting Their Estimates - 富途牛牛
Inspire Medical Systems stock hits 52-week low at $43.01 By Investing.com - Investing.com South Africa
A Look At Inspire Medical Systems (INSP) Valuation After Forecast Downgrades And Guidance Reset - Sahm
Inspire Medical Systems stock hits 52-week low at $43.01 - Investing.com
Inspire Medical Systems director Shawn McCormick sells $31,535 stock - Investing.com UK
Inspire Medical Systems director Shawn McCormick sells $31,535 stock By Investing.com - Investing.com South Africa
Director at Inspire Medical (NYSE: INSP) sells 696 company shares - Stock Titan
Investors Shouldn't Be Too Comfortable With Inspire Medical Systems' (NYSE:INSP) Earnings - Moomoo
Things Look Grim For Inspire Medical Systems, Inc. (NYSE:INSP) After Today's Downgrade - Yahoo Finance
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Is a 20.50% Potential Upside Worth the Investment? - DirectorsTalk Interviews
Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Outlook And Filing Share Offering – Has The Bull Case Changed? - Sahm
Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Guidance Amid Reimbursement ChallengesWhat's Changed - Yahoo Finance
Inspire Medical Systems, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:INSP) 2026-05-08 - Seeking Alpha
INSP SEC FilingsInspire Medical 10-K, 10-Q, 8-K Forms - Stock Titan
INSP Maintained by Oppenheimer -- Rating Remains at Perform - GuruFocus
Inspire Medical Systems (NYSE:INSP) Receives Market Perform Rating from Oppenheimer - MarketBeat
Inspire Medical Systems Inc (INSP) Stock News & Articles - 24/7 Wall St.
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):